TELIX PHARMACEUTICALS, INC.

Lobbying Spend

—

Filings

Firms Hired

Active Period

2023–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	1	1
2025	—	4	1
2024	—	4	1
2023	—	4	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
HALL, RENDER, KILLIAN, HEATH & LYMAN, P.C.	—	13

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	12
SENATE	12

Most frequently reported lobbying issues

Issue Code	Description	Reports
Medicare/Medicaid	Medicare/Medicaid	13

TELIX PHARMACEUTICALS, INC. — Lobbying Disclosure | Poliscope